论文部分内容阅读
1例66岁男性患者因尿路上皮癌伴肝脏、淋巴结转移，给予注射用紫杉醇（白蛋白结合型）400 mg静脉滴注、第1天；替吉奥50 mg口服、2次/d，第1~14天；间歇1周，21 d为1个周期。共行9个周期化疗。患者诉第1~5、7~9个周期静脉滴注注射用紫杉醇（白蛋白结合型）后约15 h（次日凌晨1：00左右）出现阴茎异常勃起，约2 h后该症状自行消失。均未予特殊处理。此后因疾病进展改用免疫治疗后患者未再出现上述症状。考虑患者阴茎异常勃起可能与注射用紫杉醇（白蛋白结合型）有关。“,”A 66-year-old male urothelial carcinoma patient with liver and lymph node metastasis received an IV infusion of paclitaxel for injection (albumin bound) 400 mg on day 1 and tegafur, gimeracil and oteracil potassium capsules 50 mg orally twice daily on day 1 to day 14, the interval was 1 week, and each cycle was 21 days. A total of 9 cycles of chemotherapy were performed. The patient complained of priapism occurring about 15 hours (about 1: 00 of the next morning) after intravenous infusion of paclitaxel (albumin bound) in the cycles 1-5 and 7-9, which could disappear about 2 hours later. No special treatment was given. After that, paclitaxel for injection (albumin bound) was not used, and the patient did not have the above symptoms again after changing to immunotherapy as disease progresses. It was considered that the patient′s priapism might be related to paclitaxel for injection (albumin bound).